Results of the phase 3 ELOQUENT-2 trial of lenalidomide/dexamethasone with or without elotuzumab in relapsed/refractory multiple myeloma | Prof Sagar Lonial at ASCO 2015

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sagar Lonial, MD, Winship Cancer Institute, Emory University, Atlanta, GA, discusses the results of the randomised, open-label ... Author: EMJ Added: 06/19/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts